Walmart (WMT$146.53) earnings forecast on February 21
On Tuesday, February 21, Walmart will be announcing its earnings forecast for the upcoming year. This is a highly anticipated event, as Walmart is one of the largest retailers in the world, and its performance often reflects broader trends in the global economy.
Walmart's most recent earnings report, released in November 2022, showed strong growth in e-commerce sales, which increased by 43% compared to the same quarter the previous year. However, the company also reported slower growth in physical store sales, with a 1.9% increase compared to the same quarter the previous year.
Investors will be looking closely at Walmart's earnings forecast to see how the company expects to perform in the coming year. With the ongoing COVID-19 pandemic continuing to impact the retail industry, it's likely that Walmart's e-commerce sales will remain strong, as consumers continue to do more of their shopping online. However, the company may continue to struggle with growth in physical stores, particularly as the pandemic has led to changes in consumer behavior.
Overall, Walmart's earnings forecast will be an important indicator of the health of the retail industry, as well as broader trends in the global economy. Investors and analysts will be paying close attention to the company's performance, looking for signs of continued growth and adaptation to the changing retail landscape.
Aroon Indicator for CVS shows an upward move is likely
CVS's Aroon Indicator triggered a bullish signal on June 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 246 similar instances where the Aroon Indicator showed a similar pattern. In of the 246 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 04, 2026. You may want to consider a long position or call options on CVS as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CVS just turned positive on June 22, 2026. Looking at past instances where CVS's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVS advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The 10-day RSI Indicator for CVS moved out of overbought territory on June 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where CVS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CVS broke above its upper Bollinger Band on June 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.669) is normal, around the industry mean (4.963). P/E Ratio (44.430) is within average values for comparable stocks, (48.571). CVS's Projected Growth (PEG Ratio) (0.285) is slightly lower than the industry average of (1.298). CVS has a moderately high Dividend Yield (0.026) as compared to the industry average of (0.019). P/S Ratio (0.317) is also within normal values, averaging (0.652).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
an integrated pharmacy health care provider
Industry ManagedHealthCare
Advertisement